10.1136/gutjnl-2016-312574 Summary Keywords proton pump inhibitors, digestive diseases, microbiota, intestinal flora, Clostridium difficile , inflammatory bowel disease, short-chain fatty acids Citation Tian L, Huang C, Fu W, Gao L, Mi N, Bai M, Ma H, Zhang C, Lu Y, Zhao J, Zhang X, Jiang N, Lin Y, Yue P, Yuan J and Meng W (2023) Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota
And sometimes, it hardens and forms a bezoar
Dual Mechanism of Action: This medication has a complex mechanism of action that sets it apart, as it activates both glucose-dependent insulinotropic polypeptide (GIP) receptors and glucagon-like peptide-1 (GLP-1) receptors throughout the body
The peptides work through complementary mechanisms and may produce synergistic healing effects